Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001104659-23-120027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-16 | SGMT | Happel David | Pres, CEO, Dir | P - Purchase | $2.35 | +590 | 590 | New | +$1,386 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2023-11-16 | P | A | 590 | $2.35 | 590 | D | — | — | (F1) Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.31 per share to $2.40 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each price. |